评论：半剂量光动力疗法或阈下微脉冲激光治疗局灶性和弥漫性慢性中心性浆液性脉络膜视网膜病变：PLACE试验报告第3号 - Suppr

Suppr

超能文献

Comment on: Focal and Diffuse Chronic Central Serous Chorioretinopathy Treated With Half-Dose Photodynamic Therapy or Subthreshold Micropulse Laser: PLACE Trial Report No. 3.

作者信息

Luttrull Jeffrey K

机构信息

Ventura, California, USA.

出版信息

Am J Ophthalmol. 2020 Apr;212:186-187. doi: 10.1016/j.ajo.2019.10.037. Epub 2020 Jan 27.

DOI:10.1016/j.ajo.2019.10.037

PMID:32000971

Abstract

摘要

相似文献

Comment on: Focal and Diffuse Chronic Central Serous Chorioretinopathy Treated With Half-Dose Photodynamic Therapy or Subthreshold Micropulse Laser: PLACE Trial Report No. 3.评论：半剂量光动力疗法或阈下微脉冲激光治疗局灶性和弥漫性慢性中心性浆液性脉络膜视网膜病变：PLACE试验报告第3号

Am J Ophthalmol. 2020 Apr;212:186-187. doi: 10.1016/j.ajo.2019.10.037. Epub 2020 Jan 27.

Reply to Comment on: Focal and Diffuse Chronic Central Serous Chorioretinopathy Treated With Half-Dose Photodynamic Therapy or Subthreshold Micropulse Laser: PLACE Trial Report No. 3.对《半剂量光动力疗法或阈下微脉冲激光治疗局灶性和弥漫性慢性中心性浆液性脉络膜视网膜病变：PLACE试验报告第3号》评论的回复

Am J Ophthalmol. 2020 Apr;212:187-188. doi: 10.1016/j.ajo.2019.11.022. Epub 2020 Jan 29.

Focal and Diffuse Chronic Central Serous Chorioretinopathy Treated With Half-Dose Photodynamic Therapy or Subthreshold Micropulse Laser: PLACE Trial Report No. 3.半剂量光动力疗法或亚阈微脉冲激光治疗局灶性和弥漫性慢性中心性浆液性脉络膜视网膜病变：PLACETM 试验报告 3。

Am J Ophthalmol. 2019 Sep;205:1-10. doi: 10.1016/j.ajo.2019.03.025. Epub 2019 Apr 3.

EFFICACY OF HALF-DOSE PHOTODYNAMIC THERAPY VERSUS HIGH-DENSITY SUBTHRESHOLD MICROPULSE LASER FOR TREATING PIGMENT EPITHELIAL DETACHMENTS IN CHRONIC CENTRAL SEROUS CHORIORETINOPATHY.半剂量光动力疗法与高密度亚阈微脉冲激光治疗慢性中心性浆液性脉络膜视网膜病变色素上皮脱离的疗效比较。

Retina. 2022 Apr 1;42(4):721-729. doi: 10.1097/IAE.0000000000003363.

Re: van Dijk et al: Half-dose photodynamic therapy versus high-density subthreshold micropulse laser treatment in patients with chronic central serous chorioretinopathy: The PLACE trial (Ophthalmology. 2018;125:1547-1555).关于：范·迪克等人：慢性中心性浆液性脉络膜视网膜病变患者的半剂量光动力疗法与高密度亚阈值微脉冲激光治疗：PLACE试验（《眼科学》。2018年；125:1547 - 1555）。

Ophthalmology. 2019 Jan;126(1):e10-e11. doi: 10.1016/j.ophtha.2018.06.037. Epub 2018 Nov 22.

Re: van Dijk et al.: Half-dose photodynamic therapy versus high-density subthreshold micropulse laser treatment in patients with chronic central serous chorioretinopathy: the PLACE trial (Ophthalmology. 2018;125:1547-1555).回复：范·迪克等人：慢性中心性浆液性脉络膜视网膜病变患者的半剂量光动力疗法与高密度亚阈值微脉冲激光治疗：PLACE试验（《眼科学》。2018年；125:1547 - 1555）。

Ophthalmology. 2019 Apr;126(4):e29-e30. doi: 10.1016/j.ophtha.2018.11.004.

Comment on 'Comparison of subthreshold micropulse laser (577 nm) treatment and half-dose photodynamic therapy in patients with chronic central serous chorioretinopathy'.关于“慢性中心性浆液性脉络膜视网膜病变患者亚阈值微脉冲激光（577nm）治疗与半剂量光动力疗法的比较”的评论

Eye (Lond). 2017 Feb;31(2):345-346. doi: 10.1038/eye.2016.242. Epub 2016 Nov 4.

Response to 'Comment on 'Comparison of subthreshold micropulse laser (577 nm) treatment and half-dose photodynamic therapy in patients with chronic central serous chorioretinopathy''.对“关于‘慢性中心性浆液性脉络膜视网膜病变患者亚阈值微脉冲激光（577nm）治疗与半剂量光动力疗法的比较’的评论”的回应

Eye (Lond). 2017 Feb;31(2):346. doi: 10.1038/eye.2016.245. Epub 2016 Nov 4.

Comment on: Crossover to Photodynamic Therapy or Micropulse Laser After Failure of Primary Treatment of Chronic Central Serous Chorioretinopathy.关于《慢性中心性浆液性脉络膜视网膜病变初次治疗失败后改用光动力疗法或微脉冲激光治疗》的评论

Am J Ophthalmol. 2021 Feb;222:397. doi: 10.1016/j.ajo.2020.09.052. Epub 2020 Nov 10.

Reply to Comment on: Crossover to Photodynamic Therapy or Micropulse Laser After Failure of Primary Treatment of Chronic Central Serous Chorioretinopathy.对《慢性中心性浆液性脉络膜视网膜病变初次治疗失败后转换为光动力疗法或微脉冲激光治疗》评论的回复

Am J Ophthalmol. 2021 Feb;222:397-398. doi: 10.1016/j.ajo.2020.10.005. Epub 2020 Nov 12.

引用本文的文献

Comment on Torrellas et al. Effectiveness, Safety and Choroidal Changes of a Fovea-Sparing Technique for the Treatment of Chronic Central Serous Chorioretinopathy with Yellow Subthreshold Laser. 2023, , 1127.关于托雷拉斯等人。黄斑保留技术治疗慢性中心性浆液性脉络膜视网膜病变的有效性、安全性及脉络膜变化：黄色阈下激光治疗。2023年，，1127。（注：原文中部分逗号处信息缺失，翻译尽量按现有内容呈现）

J Clin Med. 2023 Jun 27;12(13):4302. doi: 10.3390/jcm12134302.

Central Serous Chorioretinopathy: Treatment with Laser.中心性浆液性脉络膜视网膜病变：激光治疗

Pharmaceuticals (Basel). 2020 Nov 2;13(11):359. doi: 10.3390/ph13110359.

Photodynamic Therapy with Verteporfin for Chronic Central Serous Chorioretinopathy: A Review of Data and Efficacy.维替泊芬光动力疗法治疗慢性中心性浆液性脉络膜视网膜病变：数据与疗效综述

Pharmaceuticals (Basel). 2020 Oct 29;13(11):349. doi: 10.3390/ph13110349.

Comparison of Subthreshold 577 and 810 nm Micropulse Laser Effects on Heat-Shock Protein Activation Kinetics: Implications for Treatment Efficacy and Safety.亚阈值577纳米和810纳米微脉冲激光对热休克蛋白激活动力学的影响比较：对治疗效果和安全性的启示

Transl Vis Sci Technol. 2020 Apr 28;9(5):23. doi: 10.1167/tvst.9.5.23. eCollection 2020 Apr.

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验